Jubilant Pharmova informs about board meeting
Jubilant Pharmova has informed that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026, inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026. and Recommendation of Final Dividend, if any, for the Financial Year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
